NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the medical device company’s stock.

NeuroMetrix Price Performance

Shares of NeuroMetrix stock opened at $3.60 on Friday. NeuroMetrix has a 1 year low of $2.70 and a 1 year high of $8.00. The firm’s 50-day moving average is $4.02 and its 200 day moving average is $3.72. The stock has a market cap of $7.24 million, a price-to-earnings ratio of -0.57 and a beta of 2.30.

NeuroMetrix (NASDAQ:NURO) last posted its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. The firm had revenue of $1.09 million for the quarter. NeuroMetrix had a negative net margin of 151.51% and a negative return on equity of 39.85%.

Hedge Funds Weigh In On NeuroMetrix

An institutional investor recently bought a new position in NeuroMetrix stock. Cerity Partners LLC acquired a new stake in shares of NeuroMetrix, Inc. (NASDAQ:NURO) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned about 2.80% of NeuroMetrix as of its most recent SEC filing. 19.40% of the stock is owned by hedge funds and other institutional investors.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.